two b2B - Maine’s Biotech Sector – Superheroes in Lab Coats
Moderator:
Gary Goodrich, Biotech Association of Maine; Founder, BioProcessing
Gary Goodrich organized State of Maine Pavilions at the International BIO convention in 2006 and 2007. Founded by Gary in1990 Bioprocessing manufactures diagnostic raw materials used in tests for the diagnosis and management of cancer. Gary has over 30 years of diverse biotechnology related industrial experience including cancer research, clinical lab work and management, biochemical industry R&D, and diagnostic reagent development and manufacturing. He holds an MBS in Clinical Chemistry from Northeastern University and a BS in Biochemistry from the University of Vermont. He also holds an ASCP (SC) certification as a technologist in Chemistry.
Speakers:
Bill Palin, Inverness Medical Innovations
Janet Yancy-Wrona, COO, Aiko
Janet Yancy-Wrona joined AIKO Biotechnology in 2006. AIKO is a new start-up company focusing on the discovery and development of unique treatments for pain and addiction management. Janet comes to this position after a seven year tenure with the State of Maine, first as the founding President and Director of the Maine Technology Institute where she oversaw more than $20 million in investments that support research and development leading to commercialization from Maine-based companies, and more recently as Maine’s first Director of the Office of Innovation and the Science Advisor to the Governor where she was responsible for the Science and Technology Action Plan for Maine. Janet’s background includes Bachelor’s and Doctoral degrees in biology from Wake Forest University and the University of North Carolina, respectively, and a post-doctoral fellowship at the National Institutes of Health. Janet came to Maine in 1997 as a research scientist with Idexx Laboratories, a world-leading veterinary biotechnology company located in Westbrook.
Susie Airhart, Senior Director, The Jackson Laboratory
Susan Airhart is responsible for long-term business development and product development plans for The Jackson Laboratory, which is a leading genetics research institute located in Bar Harbor. Her contributions include development and launch of JAX® Services, which provides comprehensive support to the mammalian genetics/genomics research community. Prior to joining Jackson Susan was Director, Business Development for Oncor, Inc. where she lead product development teams responsible for Oncor’s FDA approved InformÔ Her-2/neu test, which is used today to stratify breast cancer patients for treatment. Prior to Oncor she was an Instructor at Baylor College of Medicine in Houston, TX where she developed leading-edge diagnostic and research methods that are in use today.
Ed Bilsky, Director of Center of Excellence in Neurosciences, University of New England
Dr. Bilsky is currently a tenured Professor of Pharmacology at the University of New England. He has received over 3 million dollars in extramural funding to conduct translational research in the areas of pain management and addiction and has published over 55 peer-reviewed publications in leading pharmacology journals. He lectures on a variety of topics in the Colleges of Osteopathic Medicine and Health professions and directs the Center of Excellence in the Neuroscience at the university. He is co-founder of two Maine based companies, Aiko Biotechnology and the Biousian Biosystems Inc.
|
